期刊文献+

Hedgehog信号通路异常对人结肠腺癌多药耐药性的影响 被引量:5

Effec t of abnormal Hedgehog signaling pathway on multidrug resistance of human colon adenocarcinoma cells
原文传递
导出
摘要 目的:探讨Hedgehog(Hh)信号通路与人结肠腺癌细胞多药耐药的关系。方法:以结肠腺癌敏感细胞株HCT-8和多药耐药细胞株HCT-8/VCR为研究对象,采用Hh信号通路激动剂SAG及抑制剂GANT61进行干预。实验分为4组:HCT-8组、HCT-8/VCR组、HCT-8+SAG组(3nmol/L SAG干预48h)以及HCT-8/VCR+GANT61组(5μmol/L GANT61干预48h)。采用CCK-8(cell counting kit-8)法检测细胞耐药性及存活率。实时荧光定量PCR和蛋白质印迹法分别从基因和蛋白水平检测P-糖蛋白(P-glycoprotein,P-gp)及Hedgehog信号通路相关蛋白Smo和Gli1的表达。结果:HCT-8/VCR组Smo、Gli1和P-gp基因及蛋白表达高于HCT-8组(P<0.05);HCT-8+SAG组24和48h时的细胞存活率及Smo、Gli1、P-gp基因和蛋白表达水平均高于HCT-8组(P<0.05);HCT-8/VCR+GANT61组24和48h时的细胞存活率及Smo、Gli1、P-gp基因和蛋白表达均低于HCT-8/VCR(P<0.05)。结论:人结肠腺癌细胞多药耐药性与Hh信号通路异常激活有关。 Objective: To investigate the correlation between Hedgehog (Hh) signaling pathway and multidrug resistance of human colon adenocarcinoma cells. Methods: Human colon adenocarcinoma cell line HCT-8 and its vincristine (VCR)-resistant variant HCT-8/VCR cells were treated by agonist SAG or antagonist GANT61 of Hh signaling pathway, respectively. Four groups were designed for the purpose of this study: HCT-8 group, HCT-8/VCR group, HCT-8+SAG group (treated with 3 nmol/L SAG for 48 h), and HCT-8/VCR+GANT61 group (treated with 5 μmol/L GANT61 for 48 h). Then CCK-8 (cell counting kit-8) assay was used to detect the multidrug resistance and the survival rate of the cells. The expression levels of Hh signaling members Smo (Smoothened protein) and Gli1 (Gloma-associated oncoprotein-1) and P-gp (P-glycoprotein) mRNAs and proteins were determined by real-time fluorescence quantitative PCR and Western blotting, respectively. Results: The expressions of Smo, Gli1 and P-gp mRNAs and proteins in HCT-8/VCR group were higher than those in HCT-8 group (P 〈 0.05). Compared with HCT-8 group, the survival rate and the mRNA and protein expression levels of Smo, Gli1 and P-gp in HCT-8+SAG group were significantly up-regulated (P 〈 0.05). Compared with HCT-8/VCR group, the survival rate and the mRNA and protein expression levels of Smo, Gli1 and P-gp in HCT-8/VCR+GANT61 group were significantly down-regulated (P 〈 0.05). Conclusion: The multidrug resistance of human colon adenocacinoma cells may be correlated with abnormal activation of Hh signaling pathway.
出处 《肿瘤》 CAS CSCD 北大核心 2012年第11期886-891,共6页 Tumor
关键词 结肠肿瘤 抗药性 肿瘤 信号转导 猬蛋白质类 P糖蛋白 Colonic Neoplasm Drug resistance, neoplasm Signal transduction Hedgehog proteins P-glycoprotein
  • 相关文献

参考文献2

二级参考文献72

  • 1杨永彬,陈建利,万小平.Hedgehog信号通路与肿瘤的关系研究进展[J].肿瘤,2005,25(2):198-200. 被引量:6
  • 2顾燕萍,高军,李兆申.Gli在HH信号通路中作用机制及在肿瘤治疗中的应用前景[J].第二军医大学学报,2007,28(1):98-100. 被引量:5
  • 3[1]Hammerschmidt M,Bitgood MJ,McMahon AP.Protein kinase A is a common negative regulator of Hedgehog signaling in the vertebrate embryo.Genes Dev 1996; 10:647-658
  • 4[2]Johnson RL,Scott MP.New players and puzzles in the Hedgehog signaling pathway.Curr Opin Genet Dev 1998; 8:450-156
  • 5[3]Pathi S,Pagan-Westphal S,Baker DP,Garber EA,Rayhorn P,Bumcrot D,Tabin CJ,Blake Pepinsky R,Williams KP.Comparative biological responses to human Sonic,Indian,and Desert hedgehog.Mech Dev 2001; 106:107-117
  • 6[4]Denef N,Neubuser D,Perez L,Cohen SM.Hedgehog induces opposite changes in turnover and subcellular localization of patched and smoothened.Cell 2000; 102:521-531
  • 7[5]Taipale J,Cooper MK,Maiti T,Beachy PA.Patched acts catalytically to suppress the activity of Smoothened.Nature 2002; 418:892-897
  • 8[6]Chuang PT,McMahon AP.Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein.Nature 1999; 397:617-621
  • 9[7]van den Brink GR,Hardwick JC,Nielsen C,Xu C,ten Kate FJ,Glickman J,van Deventer SJ,Roberts DJ,Peppelenbosch MP.Sonic hedgehog expression correlates with fundic gland differentiation in the adult gastrointestinal tract.Gut 2002; 51:628-633
  • 10[8]Nielsen CM,Williams J,van den Brink GR,Lauwers GY,Roberts DJ.Hh pathway expression in human gut tissues and in inflammatory gut diseases.Lab Invest 2004; 84:1631-1642

共引文献17

同被引文献36

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部